Industry Wants Greater Transparency in FDA Meeting Decisions
Earlier this year, the United States Food and Drug Administration (FDA) sought comments on the best practices for meeting…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
PhRMA
Comments Praise and Call for Clarification on FDA DAP Draft Guidance
The United States Food and Drug Administration (FDA) received more than 130 comments on its draft guidance on clinical diversity,…
Maine Gift Ban: Proposed Regulations Issued – $250 Limit on…
After several years, the Maine Board of Pharmacy issued its Notice of Agency Rule-making Proposal related to its gift ban law that…
Physician Payment Sunshine Act: Politicians and Groups React to CMS Missed…
A diverse group of organizations and the congressional sponsors are asking HHS to give some guidance as to the time frame for the…
Vermont Data Mining Law Struck Down – Next Stop Supreme Court?
A recent opinion from the United States Court of Appeals for the First Circuit concluded that a Vermont law, which banned data…
Medical Device CEO Jeff Binder Stands Up for Corporate Support of…
Criticism surrounding commercially supported continuing medical education (CME) has remained constant over the past several years,…
Billy Tauzin Leaving PhRMA
Last week, Billy Tauzin, a 66-year-old cancer survivor, and former Congressman from Louisiana, announced that he would be…